Farther Finance Advisors’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.39K Buy
7,397
+7,297
+7,297% +$11.4K ﹤0.01% 4658
2026
Q2
$176 Hold
100
– – ﹤0.01% 5736
2026
Q1
$199 Hold
100
– – ﹤0.01% 5433
2025
Q4
$159 Hold
100
– – ﹤0.01% 5244
2025
Q3
$233 Hold
100
– – ﹤0.01% 4693
2025
Q2
$126 Hold
100
– – ﹤0.01% 4280
2025
Q1
$84 Hold
100
– – ﹤0.01% 4089
2024
Q4
$159 Hold
100
– – ﹤0.01% 3707
2024
Q3
$196 Hold
100
– – ﹤0.01% 3657
2024
Q2
$159 Sell
100
-377
-79% -$1.21K ﹤0.01% 3526
2024
Q1
$2.41K Sell
477
-5
-1% -$31 ﹤0.01% 2405
2023
Q4
$2.76K Buy
482
+382
+382% +$1.89K ﹤0.01% 2286
2023
Q3
$478 Hold
100
– – ﹤0.01% 2284
2023
Q2
$425 Hold
100
– – ﹤0.01% 2195
2023
Q1
$531 Hold
100
– – ﹤0.01% 1993
2022
Q4
$628 Buy
+100
New +$890 ﹤0.01% 1785

Other funds holding CRBU

Farther Finance Advisors's CRBU Position: Q3 2026 in Review

Farther Finance Advisors increased its Caribou Biosciences (CRBU) stake by 7,297% in Q3 2026, buying an estimated $11.4K and bringing the position to 7,397 shares worth $9.39K. The position accounts for ﹤0.01% of the portfolio, ranked #4658.

Farther Finance Advisors first reported a position in CRBU in Q4 2022 and has held it in 16 quarters since. 7 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • Farther Finance Advisors held 7,397 shares of Caribou Biosciences worth $9.39K as of Q3 2026.
  • Farther Finance Advisors bought 7,297 Caribou Biosciences shares in Q3 2026, an estimated $11.4K.
  • Caribou Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4658 holding.
  • Farther Finance Advisors first reported a position in Caribou Biosciences in Q4 2022 and has held it in 16 quarters since.
  • 7 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.